ACKR3 and central nervous system cancer: ACKR3, formerly known as CXCR7/RDC1, has also been investigated in glioma patient tissue where its expression pattern appears quite inconstant: several studies highlight an increased mRNA expression in GBM tissue samples compared to non-malignant brain samples [41,42], while other studies do not [43].